COVID-19 pandemic has turned out to be a major growth determinant in the industrial automation sector. With the integration of digital infrastructure to monitor and control public health, industrial automation has taken a new shape. This crisis has enhanced the value of IT and digital transformation across different sectors and industries.
The medical devices industry in the past decade has witnessed unprecedented growth owing to improved and innovative technologies and the development of state-of-the-art infrastructural facilities. Technologies such as 3D printing offer market players a plethora of growth opportunities in the field of personalized medicine. Faster regulatory approvals and consistent R&D activities have had a positive impact on the medical devices as well as pharmaceutical industry.
The detection of pathogens is important to the prevention and identification of health problems and for a better lifestyle. The advent of new technologies has brought in new and promising approach such as membrane filtering techniques, used mostly to separate the pathogens from food products another useful technique is antibody-labeled magnets.
To Understand How Our Report Information Can Bring Difference, Ask for a brochure @ https://www.persistencemarketresearch.com/samples/8866
Progresses in DNA sequencing technology have made it possible to sequence complete microbial genomes efficiently and rapidly. Access to DNA sequences of complete microbial genomes provides new opportunities in designing innovative approaches for pathogen detection and in development of drug. New strategies are coming up for the prevention and treatment of chronic diseases from certain pathogens as etiologic agents. Several programs have been initiated for research and development of innovated and modern medicines and vaccines. Biomedical Advanced Research and Development Authority is an initiative by the U.S. Department of Health and Human Services; it provides systematic and integrated approach to the development and purchase of the drugs, vaccines, diagnostic tools and therapies necessary for medical emergencies involving blood borne pathogens such as Hepatitis B virus (HBV), hepatitis C virus (HCV) and HIV (human immunodeficiency virus).
The growth of this market is chiefly credited to the high prevalence of infectious diseases, technological advances, growing concern for safety; government initiatives, bioterrorism surveillance and high healthcare expenditure are expected to provide the required impetus for the growth of this market. Innovation of products by association and continuous development in clinical researches are helping this market to soar. However, complicated regulatory framework, improper handling of instruments and expensive identification instruments and techniques are likely to hinder the growth of this market.
Looking for Exclusive Market Insights from Business Experts? Request a Custom Report here @ https://www.persistencemarketresearch.com/request-customization/8866
The pathogen identification and treatment market can be segmented on the basis of application, end-users and geography.
The application based pathogen identification and treatment market can be divided as biodefense, animal health care, food safety, diagnostics, pathology and clinical research. For biodefense or bioterrorism surveillance, precise analytical procedures for determining pathogenic agents are required. In animal health care community use of pathogen detection to develop numerous diagnostic tests, these are highly sensitive and reliable and for control and treatment of diseases of animals. In diagnostics, these methods are used to identify or detect toxins, infectious agents, metabolic disorders, parasites, and genetic susceptibility/resistance such as Arcanobacterium haemolyticum, Astrovirus, Baylisascaris, Clostridium difficile, Cytomegalovirus, Human bocavirus etc.
End users consists of clinical or diagnostic laboratories, hospitals, blood banks, pharmaceutical companies, biotechnological companies and culture collection repositories.
Geographically, pathogen identification and treatment market are categorized as North America, Europe, Asia Pacific, Latin America and Rest of the world.
To Gain More Insights & Stay Ahead Of The Competition, Buy Now @ https://www.persistencemarketresearch.com/checkout/8866
There are major players in pathogen identification and treatment market are
- Abbott Laboratories
- Achaogen Inc.
- Alnylam Pharmaceuticals Inc.
- Becton
- Dickinson and Company
- Biomérieux Sa
- Charles River Laboratories Inc.
- Siemens Healthcare (subsidiary of Siemens AG)
- Sigma-Aldrich Corporation
- Qiagen N.V.
- Thermo Fisher Scientific Inc.
On the basis of clinical laboratories the key players are listed as Bio-Imaging Technologies Inc.
- Bio-Reference Laboratories Inc.
- Quest Diagnostics
- Neogenomics
- RadNet Inc.
Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape
About us:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.
Contact us:
Mr. Rajendra Singh
Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com
No comments:
Post a Comment